top of page

UK TREND priority setting exercise


Results of the e-Delphi priority setting exercise in translational dermatology research have been published by the British Journal of Dermatology and are available online by following this link:


Identification of Translational Dermatology Research Priorities in the UK: Results of an e-Delphi Exercise.  E. Healy, S.J. Brown, S.M. Langan, S.G. Nicholls, K. Shams & N.J. Reynolds

Professor Sara Brown was successful in her application for a Wellcome Trust Senior Research Fellowship in Clinical Science:




Sara’s research focuses on an investigation of genetic mechanisms in atopic eczema; her grant proposal was reviewed and critiqued by members of the UK TREND steering committee and her work will involve the analysis of DNA samples collected by collaborative groups in London and Newcastle as well as Dundee.



The UK Translational Research Network in Dermatology (UK TREND) has been established to support, facilitate and further develop internationally-leading, translational research in skin biology and skin disease across the UK for the direct benefit of patient care.





Prof Eugene Healy Chair of UK TREND Steering Committee        

Prof Chris Griffiths


Advisory Committee



News and Events


BRC Clinical Training Fellow 2018

Click here for more information. Closing date 13th February 2018.


THESIS/BAD/BSID Research Course

Click here for more information.


BAD Annual Meeting, Edinburgh  3 - 5th July 2018 (including UK TREND session on 4th July)

Click here for more information.


International Investigative Dermatology (IID) 2018 Annual Meeting, Orlando, Florida

Click here for more information.


American Academy of Dermatology, 2018 Annual Meeting 16 - 20th February, San Diego, Calif

Click here for more information.

cloud 1

Professor Carsten Flohr has been awarded an NIHR grant for the study:


The TREatment of Severe Atopic Dermatitis (TREAT) Trial


Prof. Carsten Flohr and his team at St John’s Institute of Dermatology, Guy’s & St Thomas’ NHS Foundation Trust and King’s College London have been awarded funding from the NIHR Efficacy and Mechanism Evaluation Programme to conduct a randomised controlled trial assessing the effectiveness, safety and cost-effectiveness of methotrexate versus ciclosporin in the treatment of severe atopic dermatitis in children.




Click here for more information.

Professor Catherine Smith has been awarded funding from the NIHR EME programme for the APRICOT study a randomised placebo-controlled trial for Pustular Psoriasis. Click here for more information.








  Professor Carsten Flohr has been awarded a BSF grant for the study:


  The UK-Irish Atopic Eczema Systemic Therapy Cohort


  A*STAR is a multicentre, prospective, observational clinical cohort

  and bioresource of paediatric and adult patients on systemic

  immuno-modulatory therapies. Over the first three years, the study

  aims to recruit at least 200 (adult and paediatric) patients on

  conventional systemic immuno-suppressive therapy, and possibly

  patients on biologics.


More information is available in the BAD Newsletter, Autumn 2017, Volume 20 Number 3, p12-13, click here to download.

A-STAR logo
UKTREND logo 6 June 13
UKTREND logo web

UK TREND welcomes patient involvement and is delighted to have Emma Rush as a member to our Steering group.  We congratulate her on setting up a new charity Vitiligo Support UK (see here).  If you are a patient and would like to know more about research, please click here.

bottom of page